Cabergoline (Crude) is a tetracyclic ergoline derivative featuring a partially hydrogenated indole ring fused to a pyrrolizidine moiety, with a substituted piperazine side chain. Its structure retains the core 2-aminotetralin scaffold of the parent drug but exhibits a truncated cyclopropylmethyl substituent and a 6,7-dimethoxyindole ring. This impurity arises from incomplete alkylation during synthetic pathways, resulting in a reduced aromatic substitution pattern compared to Cabergoline. The compound functions as a critical HPLC reference standard for quantifying process-related impurities in API synthesis.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | Y0000472 ↗ | 170 MG | EUR 90.00 |
| USP | 1084306 ↗ | 125 mg | USD 2493.00 |
CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1
KORNTPPJEAJQIU-KJXAQDMKSA-N